“End-to-End” Strategies Achieve Better Enrollment, Diversity, and Data Collection in Clinical Trials
The revolution in cancer drug development has a caveat: Only a fraction of eligible patients take part in clinical trials. Historically, findings from studies estimate that the share of eligible ...
In the early 2000s, Paul Harris, a research informatics faculty member and bioengineer at Vanderbilt University Medical Center, noticed a pressing problem. While working with research teams, he found ...
For a project in Bangladesh, Prof. Mushfiq Mobarak and his team used machine-learning models applied to mobile phone records ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results